These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 27992469)
1. Statins Have No Additional Benefit for Pulmonary Hypertension: A Meta-Analysis of Randomized Controlled Trials. Wang L; Qu M; Chen Y; Zhou Y; Wan Z PLoS One; 2016; 11(12):e0168101. PubMed ID: 27992469 [TBL] [Abstract][Full Text] [Related]
2. Benefits of statins in chronic obstructive pulmonary disease patients with pulmonary hypertension: A meta-analysis. Wang G; Shang W; Ren Y; Liu S; Ren X; Wei S; Han D Eur J Intern Med; 2019 Dec; 70():39-42. PubMed ID: 31679886 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Pulmonary Arterial Hypertension-specific Therapy in Pulmonary Arterial Hypertension: A Meta-analysis of Randomized Controlled Trials. Liu HL; Chen XY; Li JR; Su SW; Ding T; Shi CX; Jiang YF; Zhu ZN Chest; 2016 Aug; 150(2):353-66. PubMed ID: 27048870 [TBL] [Abstract][Full Text] [Related]
4. Additional use of a phosphodiesterase 5 inhibitor in patients with pulmonary hypertension secondary to chronic systolic heart failure: a meta-analysis. Wu X; Yang T; Zhou Q; Li S; Huang L Eur J Heart Fail; 2014 Apr; 16(4):444-53. PubMed ID: 24464734 [TBL] [Abstract][Full Text] [Related]
5. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial. Tapson VF; Torres F; Kermeen F; Keogh AM; Allen RP; Frantz RP; Badesch DB; Frost AE; Shapiro SM; Laliberte K; Sigman J; Arneson C; Galiè N Chest; 2012 Dec; 142(6):1383-1390. PubMed ID: 22628490 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Statins for Pulmonary Hypertension: A Meta-Analysis of Randomised Controlled Trials. Zhang Y; Zeng W; Cheng S; Chen Z; Xue J; Wang Q; Ou M; Cheng K Heart Lung Circ; 2017 May; 26(5):425-432. PubMed ID: 27769753 [TBL] [Abstract][Full Text] [Related]
7. Statin therapy improves survival in patients with severe pulmonary hypertension: a propensity score matching study. Holzhauser L; Hovnanians N; Eshtehardi P; Mojadidi MK; Deng Y; Goodman-Meza D; Msaouel P; Ko YA; Zolty R Heart Vessels; 2017 Aug; 32(8):969-976. PubMed ID: 28303379 [TBL] [Abstract][Full Text] [Related]
8. The effects of statins on blood pressure in normotensive or hypertensive subjects--a meta-analysis of randomized controlled trials. Banach M; Nikfar S; Rahimi R; Bielecka-Dabrowa A; Pencina MJ; Mikhailidis DP; Narkiewicz K; Rysz J; Ray KK; Abdollahi M; Int J Cardiol; 2013 Oct; 168(3):2816-24. PubMed ID: 23602289 [TBL] [Abstract][Full Text] [Related]
9. Do changes of 6-minute walk distance predict clinical events in patients with pulmonary arterial hypertension? A meta-analysis of 22 randomized trials. Savarese G; Paolillo S; Costanzo P; D'Amore C; Cecere M; Losco T; Musella F; Gargiulo P; Marciano C; Perrone-Filardi P J Am Coll Cardiol; 2012 Sep; 60(13):1192-201. PubMed ID: 22995024 [TBL] [Abstract][Full Text] [Related]
10. Statin therapy for the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials. Wang Z; Zhang Y; Gao M; Wang J; Wang Q; Wang X; Su L; Hou Y Pharmacotherapy; 2011 Nov; 31(11):1051-62. PubMed ID: 22026393 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of phosphodiesterase type-5 inhibitors for pulmonary arterial hypertension: A meta-analysis focusing on 6MWD. He CJ; Chen SJ; Wang J; Zhu CY; Yin YH Pulm Pharmacol Ther; 2015 Jun; 32():24-8. PubMed ID: 25843006 [TBL] [Abstract][Full Text] [Related]
12. Combination therapy improves exercise capacity and reduces risk of clinical worsening in patients with pulmonary arterial hypertension: a meta-analysis. Zhu B; Wang L; Sun L; Cao R J Cardiovasc Pharmacol; 2012 Oct; 60(4):342-6. PubMed ID: 22691882 [TBL] [Abstract][Full Text] [Related]
13. Udenafil improves exercise capacity in patients with chronic obstructive pulmonary disease: a prospective study. Park JS; Lim HJ; Cho YJ; Lee JH; Yoon HI; Lee CT COPD; 2012 Aug; 9(5):499-504. PubMed ID: 22946546 [TBL] [Abstract][Full Text] [Related]
14. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial. Tapson VF; Jing ZC; Xu KF; Pan L; Feldman J; Kiely DG; Kotlyar E; McSwain CS; Laliberte K; Arneson C; Rubin LJ; Chest; 2013 Sep; 144(3):952-958. PubMed ID: 23669822 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the simvastatin effects in the treatment of pulmonary hypertension (PH). Shahmiri SS; Adeli SH; Mousavi SA; Mostafapour E; Fereshtehnejad SM; Namegh B; Ziaeenejad MT Lijec Vjesn; 2009 Nov; 131 Suppl 6():12-5. PubMed ID: 22046626 [TBL] [Abstract][Full Text] [Related]
16. Combination therapy in pulmonary arterial hypertension: a meta-analysis. Bai Y; Sun L; Hu S; Wei Y Cardiology; 2011; 120(3):157-65. PubMed ID: 22212696 [TBL] [Abstract][Full Text] [Related]
17. Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation. Calcaianu G; Canuet M; Schuller A; Enache I; Chaouat A; Kessler R Respiration; 2016; 91(1):9-17. PubMed ID: 26492415 [TBL] [Abstract][Full Text] [Related]